Acylcarnitine profile in neonatal hypoxic-ischemic encephalopathy: The value of butyrylcarnitine as a prognostic marker

Optimal prognostic markers evaluating early neuroprotective interventions in neonatal hypoxic-ischemic encephalopathy (HIE) are lacking. This study was designed to assess the prognostic value of acylcarnitines in neonatal HIE. An observational cohort study was conducted over 10 years in 67 HIE. Vari...

Descripción completa

Detalles Bibliográficos
Autores principales: López-Suárez, Olalla, Concheiro-Guisán, Ana, Sánchez-Pintos, Paula, Cocho, Jose A., Fernández Lorenzo, José R., Couce, María L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485840/
https://www.ncbi.nlm.nih.gov/pubmed/30985723
http://dx.doi.org/10.1097/MD.0000000000015221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485840/
https://www.ncbi.nlm.nih.gov/pubmed/30985723
http://dx.doi.org/10.1097/MD.0000000000015221

Ejemplares similares